Department of Neurology

Neuroscience Research - Current Studies

For more information on any study, please contact Senior Clinical Research Coordinator Barbara Lokaitis, BA, CCRP.

Email: blokaitis@siumed.edu
Phone: 217.545.9737
PI Title Link
Abdelhak The Randomized, Concurrent Controlled Trial to Assess the Penumbra System’s Safety and effectiveness in the Treatment of Acute Stroke (THERAPY)  
     
Ala A Phase 2 multi-center, randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer’s
Disease (US202)
 
Ala A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Efficacy and Safety Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer’s Disease  
Ala A Randomized, Double-Blind, Placebo-Controlled, Parallel, 26-Week, Phase 3 Study of Two Doses of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Partial Agonist, or Placebo in subjects with Mild to Moderate Probable Alzheimer’s Disease with or without Acetylcholinesterase Inhibitor Medication  
Ala A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of MK-7622 as an Adjunctive Therapy to Donepezil for Symptomatic Treatment in Subjects with Alzheimer’s Disease  
Ala A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral β-Amyloid When Compared With Postmortem Histopathology  
Ala Beta-amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer’s Disease (AD) in Subjects with Mild Cognitive Impairment (MCI)  
Ala Caregiver Characteristics That May Predict When Patients With Alzheimer Disease Are Placed in Long Term Care Facilities  
Ala Consistency of Resting state networks in Healthy Adult and Elderly Subjects  
     
Anderson Objective Auditory Electrophysiological Analysis of Chemo Brain  
     
E. Hascup Cognition and Glutamate neurotransmission in a mouse model of Alzheimer's disease Click here
     
Gilchrist International GBS Outcome Study  
Gilchrist 302:  A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-MG-301 TO EVAULATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN SUBJECTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (gMG)  
     
Peng 1105: A randomized, double-blind, placebo-controlled, parallel group, multi-center trial of pregabalin as adjunctive therapy in pediatric and adult subjects with primary generalized tonic-clonic seizures  
     
Siddiqui Stroke Hyperglycemia Insulin Network Effort (SHINE)  
Siddiqui Platelet-Oriented Inhibition in new TIA (POINT)  
Siddiqui Randomized Evaluation of Recurrent Stroke comparing PFO Closure to Established Current Standard of Care Treatment  
Siddiqui Antihypertensive Treatment of Cerebral Hemorrhage (ATACH II)  
     
Zec Diagnosis of Dementia: Sensitivity of Neuropsychological Tests